Industry News's blog

DMCA.com Protection Status
Industry News's picture
Keywords: 
BARA-MED Select hyperbaric chamber

By the WoundSource Editors

Southampton, PA – September 24, 2015 – Environmental Tectonics Corporation (OTC Pink: ETCC) announced that the U.S. Patent and Trademark Office has issued a noteworthy patent, U.S. Patent No. 9,138,366, which covers certain hyperbaric chambers with undercarriage-gurney-storage compartments, such as those available on ETC's BARA-MED® Select™ chamber.

Blog Category: 
Industry News's picture

By The Alliance of Wound Care Stakeholders

The Alliance of Wound Care Stakeholders submitted two sets of formal written comments to the Centers for Medicare and Medicaid Services (CMS) during September 2015 in response to the proposed updates to CMS' outpatient payment rates and to the physician payment schedule. The Alliance's comments focused on provisions that have potential impact to wound care. These proposed rules have important implications to health care providers and health care administrators as CMS sets future reimbursement for services and procedures.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

September 8, 2015 – DermaRite®, manufacturers of cost effective advanced wound care, skin care and nutritional supplements for health and senior-care facilities, is proud to introduce their Healing In D.E.P.T.H. program.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Gaithersburg, MD – July 30, 2015 – Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced that its previously reported collaboration with Net Health to add data collection functionality within WoundExpert® for the Aurix™ Coverage with Evidence Development (CED) program (Au Study) will go live in August.

Blog Category: 
Industry News's picture

By The Alliance of Wound Care Stakeholders

The Alliance of Wound Care Stakeholders submitted formal comments in response to the Novitas draft local coverage determination (LCD) for Hyperbaric Oxygen Therapy (HBOT) DL35021.

Blog Category: 
Industry News's picture
Keywords: 
Span-America Topper

By the WoundSource Editors

Greenville, SC – June 4, 2015 – Span-America Medical Systems, Inc. has launched The Topper Microenvironment Manager™, an add-on powered mattress cover designed to reduce heat, moisture, shearing, pressure and odor as an aid in the prevention and treatment of pressure ulcers through stage IV.

Blog Category: 
Industry News's picture

By The Alliance of Wound Care Stakeholders

The Alliance of Wound Care Stakeholders submitted formal written comments in response to the First Coast Service Option (FCSO) draft local coverage determination (LCD) for Application of Skin Substitute Grafts for Treatment of Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU) of Lower Extremities DL36013 - note: this directs you to a CMS landing page where you must accept a license/disclaimer, and once accepted it connects you to the LCD).

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Topeka, KS – April 13, 2015 – Lohmann & Rauscher (L&R) is pleased to announce the launch of Debrisoft® Active Monofilament Debriding Device for the U.S. wound care market. Debrisoft has been available in Europe for several years where it has rapidly established itself as a proven alternative to both traditional and advanced debriding products.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Irving, TX – March 2, 2015 – GWM Products, LLC, manufacturer of the RTD® Wound Care Dressing announced today it has changed its name to Keneric Healthcare. The name change comes as part of the company's plan to continue building its presence in the advanced wound care market. Under the new Keneric Healthcare name, the company plans to expand its product offerings for the RTD Wound Dressing line and its portfolio of advanced wound care products.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Gaithersburg, MD – February 19, 2015 – Nuo Therapeutics, Inc. (OTCQX: NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

Blog Category: 

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.